Skip to main content
. 2021 Mar 24;13(4):1052. doi: 10.3390/nu13041052

Table 6.

Gastrointestinal and urinary symptoms of non-skeletal fluorosis in a 6-month eggshell powder intervention in treatment and control groups.

Gastrointestinal and Urinary Symptoms § of Non-Skeletal Fluorosis, N (%)
Loss of Appetite Nausea Bloating in Stomach Polydipsia Polyuria Constipation
Group Yes No Yes No Yes No Yes No Yes No Yes No
Baseline IG (n = 39) 14 (35.9) 25 (64.1) 21 (53.8) 18 (46.2) 7 (17.9) 32 (82.1) 6 (15.4) 33 (84.6) 2 (5.1) 37 (94.9) 31 (79.5) 8 (20.5)
CG (n = 39) 12 (30.8) 27 (69.2) 19 (48.7) 20 (51.3) 8 (20.5) 31 (79.5) 3 (7.7) 36 (92.3) 3 (7.7) 36 (92.3) 34 (87.2) 5 (12.8)
RR (95%CI) 1.15 (0.87, 2.53) 1.17 (0.84, 1.64) 1.31 (0.82, 2.11) 0.91 (0.60, 1.37) 0.96 (0.72, 1.28) 1.04 (0.74, 1.47)
Endline IG (n = 39) 4 (10.3) 35 (89.7) 5 (12.8) 34 (87.2) 7 (17.9) 32 (82.1) 5 (12.8) 34 (87.2) 2 (5.1) 37 (94.9) 10 (25.6) 29 (74.4)
CG (n = 39) 17 (43.6) 22 (56.4) 21 (53.8) 18 (46.2) 9 (23.1) 30 (76.9) 7 (17.9) 32 (82.1) 4 (10.3) 35 (89.7) 13 (33.3) 26 (66.7)
RR (95%CI) 0.23 (0.09, 0.64) * 0.24 (0.10, 0.58) * 0.78 (0.32, 1.88) 0.71 (0.25, 2.06) 0.50 (0.10, 2.57) 0.77 (0.38, 1.54)

§ Testing was done according to Shashi et al. [22]; * Statistically significant association observed at p-value < 0.05. IG = Intervention group, CG = Control group.